Skip to main content
SpringerLink
Log in

Development of Safe and Efficacious Bluetongue Virus Vaccines

  • Chapter
  • First Online:
Molecular Vaccines

Abstract

Bluetongue virus (BTV) infection results in an agriculturally important disease of livestock. Traditionally BTV outbreaks were controlled by the use of attenuated live virus vaccines. However recent BTV outbreaks in Europe had been controlled by killed virus vaccine. These vaccines are not DIVA-compliant (unable to differentiate between infected and vaccinated animals). This review summarises the current efforts in development of DIVA-compliant subunit vaccines, with emphasis of virus-like particles as improved bluetongue vaccines.

Although current commercial vaccines that have been used to control virus spread in Europe are mainly based on inactivated viruses, these are not DIVA compliant. Thus, this has lead to many new approaches in order to develop a DIVA-compliant vaccine with accompanying tests. This review describes the different technologies, with emphasis of virus-like particles as improved bluetongue vaccines.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gambles, R.M.: Bluetongue of sheep in Cyprus. J. Comp. Pathol. 59, 176–190 (1949)

    Google Scholar 

  2. Manso-Ribeiro, J., et al.: Fievre catarrhale du mouton (blue-tongue). Bull. Off. Int. Epizoot. 48, 350–367 (1957)

    Google Scholar 

  3. Howell, P.G.: Emerging diseases of animals: Bluetongue. FAO Agric. Stud. 61, 109 (1963)

    Google Scholar 

  4. Purse, B.V., et al.: Climate change and the recent emergence of bluetongue in Europe. Nat. Rev. Microbiol. 3, 171–181 (2005)

    CAS  PubMed  Google Scholar 

  5. Shaw, A.E., et al.: Development and initial evaluation of a real-time RT-PCR assay to detect bluetongue virus genome segment 1. J. Virol. Methods 145, 115– 126 (2007)

    CAS  PubMed  Google Scholar 

  6. Elbers, A.R., van der Spek, A.N., van Rijn, P.A.: Epidemiologic characteristics of bluetongue virus serotype 8 laboratory-confirmed outbreaks in The Netherlands in 2007 and a comparison with the situation in 2006. Prev. Vet. Med. 92, 1–8 (2009)

    PubMed  Google Scholar 

  7. OIE: Notifiable diseases list. http://www.oie.int/eng/maladies/en_classification2009.htm?e1d7 (2009)

  8. MacLachlan, N.J.: The pathogenesis and immunology of bluetongue virus infection of ruminants. Comp. Immunol. Microbiol. Infect. Dis. 17, 197–206 (1994)

    CAS  PubMed  Google Scholar 

  9. Hourrigan, J.L., Klingsporn, A.L.: Bluetongue: the disease in cattle. Aust. Vet. J. 51, 170–174 (1975)

    CAS  PubMed  Google Scholar 

  10. Meroc, E., et al.: Bluetongue in Belgium: episode II. Transbound. Emerg. Dis. 56, 39–48 (2009)

    CAS  PubMed  Google Scholar 

  11. Spreull, J.: Malarial catarrhal fever (bluetongue) of sheep in South Africa. J. Comp. Pathol. Therap. 18, 321–337 (1905)

    Google Scholar 

  12. Erasmus, B.J.: Bluetongue in sheep and goats. Aust. Vet. J. 51, 65–170 (1975)

    Google Scholar 

  13. Laegreid, W.W., Burrage, T.G., Stone-Marschat, M., Skowronek, A.: Electron microscopic evidence for endothelial infection by African horsesickness virus. Vet. Pathol. 29, 554–556 (1992)

    CAS  PubMed  Google Scholar 

  14. Mahrt, C.R., Osburn, B.I.: Experimental bluetongue virus infection of sheep; effect of vaccination: pathologic, immunofluorescent, and ultrastructural studies. Am. J. Vet. Res. 47, 1198–1203 (1986)

    CAS  PubMed  Google Scholar 

  15. Tsai, K.S., Karstad, L.: Epizootic hemorrhagic disease virus of deer: an electron microscopic study. Can. J. Microbiol. 16, 427–432 (1970)

    CAS  PubMed  Google Scholar 

  16. Pini, A.: Study on the pathogenesis of bluetongue: replication of the virus in the organs of infected sheep. Onderstepoort J. Vet. Res. 43, 159–164 (1976)

    CAS  PubMed  Google Scholar 

  17. DeMaula, C.D., Leutenegger, C.M., Bonneau, K.R., MacLachlan, N.J.: The role of endothelial cell-derived inflammatory and vasoactive mediators in the pathogenesis of bluetongue. Virology 296, 330–337 (2002)

    CAS  PubMed  Google Scholar 

  18. DeMaula, C.D., Leutenegger, C.M., Jutila, M.A., MacLachlan, N.J.: Bluetongue virus-induced activation of primary bovine lung microvascular endothelial cells. Vet. Immunol. Immunopathol. 86, 147–157 (2002)

    CAS  PubMed  Google Scholar 

  19. De Clercq, K., et al.: Transplacental bluetongue infection in cattle. Vet. Rec. 162, 564 (2008)

    PubMed  Google Scholar 

  20. Gibbs, E.P., Lawman, M.J.P., Herniman, K.A.J.: Preliminary observations on transplacentar infection of bluetongue virus in sheep – a possible overwintering mechanism. Res. Vet. Sci. 27, 118–120 (1979)

    CAS  PubMed  Google Scholar 

  21. Darpel, K.E., et al.: Transplacental transmission of bluetongue virus 8 in cattle, UK. Emerg. Infect. Dis. 15, 2025–2028 (2009)

    PubMed  Google Scholar 

  22. De Clercq, K., et al.: Transplacental infection and apparently immunotolerance induced by a wild-type bluetongue virus serotype 8 natural infection. Transbound. Emerg. Dis. 55, 352–359 (2008)

    PubMed  Google Scholar 

  23. MacLachlan, N.J., et al.: Detection of bluetongue virus in the blood of inoculated calves: comparison of virus isolation, PCR assay, and in vitro feeding of Culicoides variipennis. Arch. Virol. 136, 1–8 (1994)

    CAS  PubMed  Google Scholar 

  24. Hemati, B., et al.: Bluetongue virus targets conventional dendritic cells in skin lymph. J. Virol. 83, 8789– 8799 (2009)

    CAS  PubMed  Google Scholar 

  25. McLaughlin, B.E., DeMaula, C.D., Wilson, W.C., Boyce, W.M., MacLachlan, N.J.: Replication of bluetongue virus and epizootic hemorrhagic disease virus in pulmonary artery endothelial cells obtained from cattle, sheep, and deer. Am. J. Vet. Res. 64, 860–865 (2003)

    PubMed  Google Scholar 

  26. Whetter, L.E., Maclachlan, N.J., Gebhard, D.H., Heidner, H.W., Moore, P.F.: Bluetongue virus infection of bovine monocytes. J. Gen. Virol. 70(Pt 7), 1663–1676 (1989)

    CAS  PubMed  Google Scholar 

  27. Stewart, M.E., Roy, P.: Role of cellular caspases, nuclear factor-kappa B and interferon regulatory factors in Bluetongue virus infection and cell fate. Virol. J. 7, 362 (2010)

    CAS  PubMed  Google Scholar 

  28. Mortola, E., Noad, R., Roy, P.: Bluetongue virus outer capsid proteins are sufficient to trigger apoptosis in mammalian cells. J. Virol. 78, 2875–2883 (2004)

    CAS  PubMed  Google Scholar 

  29. Verwoerd, D.W., Els, H.J., De Villiers, E.M., Huismans, H.: Structure of the bluetongue virus capsid. J. Virol. 10, 783–794 (1972)

    CAS  PubMed  Google Scholar 

  30. Roy, P.: Orbiviruses and their replication. In: Fields’ Virology - Fifth Edition, (Knipe, D.M. et al., eds.). Lippincott Williams & Wilkins, Philadelphia, USA. (2007)

    Google Scholar 

  31. Verwoerd, D.W., Louw, H., Oellermann, R.A.: Characterization of bluetongue virus ribonucleic acid. J. Virol. 5, 1–7 (1970)

    CAS  PubMed  Google Scholar 

  32. Firth, A.E.: Bioinformatic analysis suggests that the Orbivirus VP6 cistron encodes an overlapping gene. Virol. J. 5, 48 (2008)

    PubMed  Google Scholar 

  33. Ratinier, M., et al.: Identification and characterization of a novel non-structural protein of bluetongue virus. PLoS Pathog. 7, e1002477 (2011)

    CAS  PubMed  Google Scholar 

  34. Forzan, M., Marsh, M., Roy, P.: Bluetongue virus entry into cells. J. Virol. 81, 4819–4827 (2007)

    CAS  PubMed  Google Scholar 

  35. Hassan, S.H., Wirblich, C., Forzan, M., Roy, P.: Expression and functional characterization of bluetongue virus VP5 protein: role in cellular permeabilization. J. Virol. 75, 8356–8367 (2001)

    CAS  PubMed  Google Scholar 

  36. Hassan, S.S., Roy, P.: Expression and functional characterization of bluetongue virus VP2 protein: role in cell entry. J. Virol. 73, 9832–9842 (1999)

    CAS  PubMed  Google Scholar 

  37. Nason, E.L., et al.: Interactions between the inner and outer capsids of bluetongue virus. J. Virol. 78, 8059– 8067 (2004)

    CAS  PubMed  Google Scholar 

  38. Zhang, X., et al.: Bluetongue virus coat protein VP2 contains sialic acid-binding domains, and VP5 resembles enveloped virus fusion proteins. Proc. Natl. Acad. Sci. U.S.A. 107, 6292–6297 (2010)

    CAS  PubMed  Google Scholar 

  39. Huismans, H., Erasmus, B.J.: Identification of the serotype-specific and group-specific antigens of bluetongue virus. Onderstepoort J. Vet. Res. 48, 51–58 (1981)

    CAS  PubMed  Google Scholar 

  40. Huismans, H., van der Walt, N.T., Cloete, M., Erasmus, B.J.: Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep. Virology 157, 172–179 (1987)

    CAS  PubMed  Google Scholar 

  41. Huismans, H., van der Walt, N.T., Erasmus, B.J.: Immune response against the purified serotype specific antigen of bluetongue virus and initial attempts to clone the gene that codes for the synthesis of this protein. Prog. Clin. Biol. Res. 178, 347–353 (1985)

    CAS  PubMed  Google Scholar 

  42. Rossitto, P.V., MacLachlan, N.J.: Neutralizing epitopes of the serotypes of bluetongue virus present in the United States. J. Gen. Virol. 73(Pt 8), 1947– 1952 (1992)

    CAS  PubMed  Google Scholar 

  43. Roy, P., Urakawa, T., Van Dijk, A.A., Erasmus, B.J.: Recombinant virus vaccine for bluetongue disease in sheep. J. Virol. 64, 1998–2003 (1990)

    CAS  PubMed  Google Scholar 

  44. Gould, A.R., Eaton, B.T.: The amino acid sequence of the outer coat protein VP2 of neutralizing monoclonal antibody-resistant, virulent and attenuated bluetongue viruses. Virus Res. 17, 161–172 (1990)

    CAS  PubMed  Google Scholar 

  45. Heidner, H.W., Rossitto, P.V., MacLachlan, N.J.: Identification of four distinct neutralizing epitopes on bluetongue virus serotype 10 using neutralizing monoclonal antibodies and neutralization-escape variants. Virology 176, 658–661 (1990)

    CAS  PubMed  Google Scholar 

  46. White, J.R., Eaton, B.T.: Conformation of the VP2 protein of bluetongue virus (BTV) determines the involvement in virus neutralization of highly conserved epitopes within the BTV serogroup. J. Gen. Virol. 71(Pt 6), 1325–1332 (1990)

    CAS  PubMed  Google Scholar 

  47. Forzan, M., Wirblich, C., Roy, P.: A capsid protein of nonenveloped Bluetongue virus exhibits membrane fusion activity. Proc. Natl. Acad. Sci. U.S.A. 101, 2100–2105 (2004)

    CAS  PubMed  Google Scholar 

  48. Grimes, J.M., et al.: An atomic model of the outer layer of the bluetongue virus core derived from X-ray crystallography and electron cryomicroscopy. Structure 5, 885–893 (1997)

    CAS  PubMed  Google Scholar 

  49. Hewat, E.A., Booth, T.F., Roy, P.: Structure of correctly self-assembled bluetongue virus-like particles. J. Struct. Biol. 112, 183–191 (1994)

    CAS  PubMed  Google Scholar 

  50. Tan, B.H., et al.: RGD tripeptide of bluetongue virus VP7 protein is responsible for core attach-ment to Culicoides cells. J. Virol. 75, 3937–3947 (2001)

    CAS  PubMed  Google Scholar 

  51. Lourenco, S., Roy, P.: In vitro reconstitution of Bluetongue virus infectious cores. Proc. Natl. Acad. Sci. U.S.A. 108, 13746–13751 (2011)

    CAS  PubMed  Google Scholar 

  52. Browne, J.G., Jochim, M.M.: Cytopathologic changes and development of inclusion bodies in cultured cells infected with bluetongue virus. Am. J. Vet. Res. 28, 1091–1105 (1967)

    CAS  PubMed  Google Scholar 

  53. Modrof, J., Lymperopoulos, K., Roy, P.: Phosphorylation of bluetongue virus nonstructural protein 2 is essential for formation of viral inclusion bodies. J. Virol. 79, 10023–10031 (2005)

    CAS  PubMed  Google Scholar 

  54. Thomas, C.P., Booth, T.F., Roy, P.: Synthesis of bluetongue virus-encoded phosphoprotein and formation of inclusion bodies by recombinant baculovirus in insect cells: it binds the single-stranded RNA species. J. Gen. Virol. 71(Pt 9), 2073–2083 (1990)

    CAS  PubMed  Google Scholar 

  55. Bhattacharya, B., Noad, R.J., Roy, P.: Interaction between Bluetongue virus outer capsid protein VP2 and vimentin is necessary for virus egress. Virol. J. 4, 7 (2007)

    PubMed  Google Scholar 

  56. Bhattacharya, B., Roy, P.: Role of lipids on entry and exit of bluetongue virus, a complex non-enveloped virus. Viruses 2, 1218–1235 (2010)

    CAS  PubMed  Google Scholar 

  57. Celma, C.C., Roy, P.: A viral nonstructural protein regulates bluetongue virus trafficking and release. J. Virol. 83, 6806–6816 (2009)

    CAS  PubMed  Google Scholar 

  58. Urakawa, T., Roy, P.: Bluetongue virus tubules made in insect cells by recombinant baculoviruses: expression of the NS1 gene of bluetongue virus serotype 10. J. Virol. 62, 3919–3927 (1988)

    CAS  PubMed  Google Scholar 

  59. Boyce, M., Celma, C.C., Roy, P.: Bluetongue virus non-structural protein 1 is a positive regulator of viral protein synthesis. Virol. J. 9, 178 (2012)

    CAS  PubMed  Google Scholar 

  60. Wilson, A.J., Mellor, P.S.: Bluetongue in Europe: past, present and future. Philos. Trans. R. Soc. Lond. B Biol. Sci. 364, 2669–2681 (2009)

    PubMed  Google Scholar 

  61. Hofmann, M.A., et al.: Detection of Toggenburg Orbivirus by a segment 2-specific quantitative RT-PCR. J. Virol. Methods 165, 325–329 (2010)

    CAS  PubMed  Google Scholar 

  62. Maan, S., et al.: Novel bluetongue virus serotype from Kuwait. Emerg. Infect. Dis. 17, 886–889 (2011)

    PubMed  Google Scholar 

  63. Mellor, P.S.: The replication of bluetongue virus in Culicoides vectors. Curr. Top. Microbiol. Immunol. 162, 143–161 (1990)

    CAS  PubMed  Google Scholar 

  64. Wilson, A., Mellor, P.: Bluetongue in Europe: vectors, epidemiology and climate change. Parasitol. Res. 103 Suppl 1, S69–S77 (2008)

    PubMed  Google Scholar 

  65. Dargatz, D., et al.: Bluetongue surveillance methods in the United States of America. Vet. Ital. 40, 182–183 (2004)

    CAS  PubMed  Google Scholar 

  66. Mellor, P.S.: Infection of the vectors and bluetongue epidemiology in Europe. Vet. Ital. 40, 167–174 (2004)

    CAS  PubMed  Google Scholar 

  67. Walton, T.E.: The history of bluetongue and a current global overview. Vet. Ital. 40, 31–38 (2004)

    CAS  PubMed  Google Scholar 

  68. Becker, M.E., et al.: Detection of bluetongue virus RNA in field-collected Culicoides spp. (Diptera: Ceratopogonidae) following the discovery of bluetongue virus serotype 1 in white-tailed deer and cattle in Louisiana. J. Med. Entomol. 47, 269–273 (2010)

    CAS  PubMed  Google Scholar 

  69. Lager, I.A.: Bluetongue virus in South America: overview of viruses, vectors, surveillance and unique features. Vet. Ital. 40, 89–93 (2004)

    CAS  PubMed  Google Scholar 

  70. Maclachlan, N.J., Guthrie, A.J.: Re-emergence of bluetongue, African horse sickness, and other orbivirus diseases. Vet. Res. 41, 35 (2010)

    PubMed  Google Scholar 

  71. Tabachnick, W.J., Smartt, C.T., Connelly, C.R.: Bluetongue. Report No. ENY-743 (IN768), Gainesville (2008)

    Google Scholar 

  72. Elbers, A.R., et al.: Field observations during the Bluetongue serotype 8 epidemic in 2006. II. Morbidity and mortality rate, case fatality and clinical recovery in sheep and cattle in the Netherlands. Prev. Vet. Med. 87, 31–40 (2008)

    PubMed  Google Scholar 

  73. Goldsmit, L., Barzilai, E.: Isolation and propagation of bluetongue virus in embryonating chicken eggs. Prog. Clin. Biol. Res. 178, 307–318 (1985)

    CAS  PubMed  Google Scholar 

  74. Ward, M.P., Gardner, I.A., Flanagan, M.: Evaluation of an agar gel immunodiffusion test to detect infection of cattle with bluetongue viruses in Queensland, Australia. Vet. Microbiol. 45, 27–34 (1995)

    CAS  PubMed  Google Scholar 

  75. Roy, P.: From genes to complex structures of bluetongue virus and their efficacy as vaccines. Vet. Microbiol. 33, 155–168 (1992)

    CAS  PubMed  Google Scholar 

  76. Roy, P.: Nature and duration of protective immunity to bluetongue virus infection. Dev. Biol. (Basel) 114, 169–183 (2003)

    CAS  Google Scholar 

  77. Roy, P., Boyce, M., Noad, R.: Prospects for improved bluetongue vaccines. Nat. Rev. Microbiol. 7, 120– 128 (2009)

    CAS  PubMed  Google Scholar 

  78. Savini, G., MacLachlan, N.J., Sanchez-Vizcaino, J.M., Zientara, S.: Vaccines against bluetongue in Europe. Comp. Immunol. Microbiol. Infect. Dis. 31, 101–120 (2008)

    PubMed  Google Scholar 

  79. Osburn, B.I., et al.: Experimental viral-induced congenital encephalopathies. II. The pathogenesis of bluetongue vaccine virus infection in fetal lambs. Lab. Invest. 25, 206–210 (1971)

    CAS  PubMed  Google Scholar 

  80. Schultz, G., Delay, P.D.: Losses in newborn lambs associated with bluetongue vaccination of pregnancy ewes. J. Am. Vet. Med. Assoc. 127, 224–226 (1955)

    CAS  PubMed  Google Scholar 

  81. Flanagan, M., Johnson, S.J.: The effects of vaccination of Merino ewes with an attenuated Australian bluetongue virus serotype 23 at different stages of gestation. Aust. Vet. J. 72, 455–457 (1995)

    CAS  PubMed  Google Scholar 

  82. Ferrari, G., et al.: Active circulation of bluetongue vaccine virus serotype-2 among unvaccinated cattle in central Italy. Prev. Vet. Med. 68, 103–113 (2005)

    CAS  PubMed  Google Scholar 

  83. Stott, J.L., Oberst, R.D., Channell, M.B., Osburn, B.I.: Genome segment reassortment between two serotypes of bluetongue virus in a natural host. J. Virol. 61, 2670–2674 (1987)

    CAS  PubMed  Google Scholar 

  84. Batten, C.A., Maan, S., Shaw, A.E., Maan, N.S., Mertens, P.P.: A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment. Virus Res. 137, 56–63 (2008)

    CAS  PubMed  Google Scholar 

  85. Savini, G., et al.: Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle. Vet. Microbiol. 133, 1–8 (2009)

    CAS  PubMed  Google Scholar 

  86. Gethmann, J., et al.: Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions. Vaccine 27(31), 4118–4126 (2009)

    CAS  PubMed  Google Scholar 

  87. González, J.M., et al.: Possible adverse reactions in sheep after vaccination with inactivated BTV vaccines. Vet. Rec. 166, 757–758 (2010)

    PubMed  Google Scholar 

  88. Campbell, C.H., Barber, T.L., Knudsen, R.C., Swaney, L.M.: Immune response of mice and sheep to bluetongue virus inactivated by gamma irradiation. Prog. Clin. Biol. Res. 178, 639–647 (1985)

    CAS  PubMed  Google Scholar 

  89. Parker, J., Herniman, K.A., Gibbs, E.P., Sellers, R.F.: An experimental inactivated vaccine against bluetongue. Vet. Rec. 96, 284–287 (1975)

    CAS  PubMed  Google Scholar 

  90. Stott, J.L., Barber, T.L., Osburn, B.I.: Immunologic response of sheep to inactivated and virulent bluetongue virus. Am. J. Vet. Res. 46, 1043–1049 (1985)

    CAS  PubMed  Google Scholar 

  91. Stott, J.L., Osburn, B.I., Barber, T.L.: The current status of research on an experimental inactivated bluetongue virus vaccine. Proc. Ann. Meet. U. S. Anim. Health Assoc. 83, 55–62 (1979)

    Google Scholar 

  92. Steinrigl, A., Revilla-Fernandez, S., Eichinger, M., Koefer, J., Winter, P.: Bluetongue virus RNA detection by RT-qPCR in blood samples of sheep vaccinated with a commercially available inactivated BTV-8 vaccine. Vaccine 28, 5573–5581 (2010)

    CAS  PubMed  Google Scholar 

  93. Bonneau, K.R., DeMaula, C.D., Mullens, B.A., MacLachlan, N.J.: Duration of viraemia infectious to Culicoides sonorensis in bluetongue virus-infected cattle and sheep. Vet. Microbiol. 88, 115–125 (2002)

    CAS  PubMed  Google Scholar 

  94. Katz, J.B., Alstad, A.D., Gustafson, G.A., Moser, K.M.: Sensitive identification of bluetongue virus serogroup by a colorimetric dual oligonucleotide sorbent assay of amplified viral nucleic acid. J. Clin. Microbiol. 31, 3028–3030 (1993)

    CAS  PubMed  Google Scholar 

  95. Roy, P.: Use of baculovirus expression vectors: development of diagnostic reagents, vaccines and morphological counterparts of bluetongue virus. FEMS Microbiol. Immunol. 2, 223–234 (1990)

    CAS  PubMed  Google Scholar 

  96. Roy, P., Bishop, D.H., LeBlois, H., Erasmus, B.J.: Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection. Vaccine 12, 805–811 (1994)

    CAS  PubMed  Google Scholar 

  97. Boone, J.D., et al.: Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. Vaccine 25, 672–678 (2007)

    CAS  PubMed  Google Scholar 

  98. Calvo-Pinilla, E., Navasa, N., Anguita, J., Ortego, J.: Multiserotype protection elicited by a combinatorial prime-boost vaccination strategy against bluetongue virus. PLoS One 7, e34735 (2012)

    CAS  PubMed  Google Scholar 

  99. Jones, L.D., Chuma, T., Hails, R., Williams, T., Roy, P.: The non-structural proteins of bluetongue virus are a dominant source of cytotoxic T cell peptide determinants. J. Gen. Virol. 77(Pt 5), 997–1003 (1996)

    CAS  PubMed  Google Scholar 

  100. Ma, G., et al.: An equine herpesvirus type 1 (EHV-1) expressing VP2 and VP5 of serotype 8 bluetongue virus (BTV-8) induces protection in a murine infection model. PLoS One 7, e34425 (2012)

    CAS  PubMed  Google Scholar 

  101. Inumaru, S., Roy, P.: Production and characterization of the neutralization antigen VP2 of bluetongue virus serotype 10 using a baculovirus expression vector. Virology 157, 472–479 (1987)

    CAS  PubMed  Google Scholar 

  102. Wade-Evans, A.M., et al.: Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge. Virology 220, 227–231 (1996)

    CAS  PubMed  Google Scholar 

  103. Roy, P., French, T., Erasmus, B.J.: Protective efficacy of virus-like particles for bluetongue disease. Vaccine 10, 28–32 (1992)

    CAS  PubMed  Google Scholar 

  104. Stewart, M., et al.: Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus. Vaccine 28, 3047–3054 (2010)

    CAS  PubMed  Google Scholar 

  105. Stewart, M., et al.: Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection. Vaccine 30, 2131–2139 (2012)

    CAS  PubMed  Google Scholar 

  106. French, T.J., Marshall, J.J., Roy, P.: Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins. J. Virol. 64, 5695–5700 (1990)

    CAS  PubMed  Google Scholar 

  107. French, T.J., Inumaru, S., Roy, P.: Expression of two related nonstructural proteins of bluetongue virus (BTV) type 10 in insect cells by a recombinant baculovirus: production of polyclonal ascitic fluid and characterization of the gene product in BTV-infected BHK cells. J. Virol. 63, 3270–3278 (1989)

    CAS  PubMed  Google Scholar 

  108. Liu, H.M., Booth, T.F., Roy, P.: Interactions between bluetongue virus core and capsid proteins translated in vitro. J. Gen. Virol. 73(Pt 10), 2577–2584 (1992)

    CAS  PubMed  Google Scholar 

  109. Ellis, J.A., et al.: T lymphocyte subset alterations following bluetongue virus infection in sheep and cattle. Vet. Immunol. Immunopathol. 24, 49–67 (1990)

    CAS  PubMed  Google Scholar 

  110. Jeggo, M.H., Wardley, R.C., Brownlie, J.: Importance of ovine cytotoxic T cells in protection against bluetongue virus infection. Prog. Clin. Biol. Res. 178, 477–487 (1985)

    CAS  PubMed  Google Scholar 

  111. Rojas, J.M., Rodriguez-Calvo, T., Pena, L., Sevilla, N.: T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep. Vaccine 29, 6848–6857 (2011)

    CAS  PubMed  Google Scholar 

  112. de Perez de Diego, A.C., et al.: Characterization of protection afforded by a bivalent virus-like particle vaccine against bluetongue virus serotypes 1 and 4 in sheep. PLoS One 6, e26666 (2011)

    CAS  PubMed  Google Scholar 

  113. Stewart, M., et al.: Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen. Vaccine 31(3), 553–558 (2012)

    PubMed  Google Scholar 

  114. Balasuriya, U.B., et al.: The NS3 proteins of global strains of bluetongue virus evolve into regional topotypes through negative (purifying) selection. Vet. Microbiol. 126, 91–100 (2008)

    CAS  PubMed  Google Scholar 

  115. Mertens, P.P., et al.: Design of primers and use of RT-PCR assays for typing European bluetongue virus isolates: differentiation of field and vaccine strains. J. Gen. Virol. 88, 2811–2823 (2007)

    CAS  PubMed  Google Scholar 

  116. Nomikou, K., et al.: Evolution and phylogenetic analysis of full-length VP3 genes of Eastern Mediterranean bluetongue virus isolates. PLoS One 4, e6437 (2009)

    PubMed  Google Scholar 

  117. Pritchard, L.I., et al.: Genetic diversity of bluetongue viruses in south east Asia. Virus Res. 101, 193–201 (2004)

    CAS  PubMed  Google Scholar 

  118. Boyce, M., Celma, C.C., Roy, P.: Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts. J. Virol. 82, 8339–8348 (2008)

    CAS  PubMed  Google Scholar 

  119. Matsuo, E., Roy, P.: Bluetongue virus VP6 acts early in the replication cycle and can form the basis of chimeric virus formation. J. Virol. 83, 8842–8848 (2009)

    CAS  PubMed  Google Scholar 

  120. Matsuo, E., et al.: Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge. J. Virol. 85, 10213–10221 (2011)

    CAS  PubMed  Google Scholar 

  121. Barros, S.C., et al.: A DIVA system based on the detection of antibodies to non-structural protein 3 (NS3) of bluetongue virus. Vet. Microbiol. 137, 252–259 (2009)

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK

    Polly Roy PhD & Meredith Stewart PhD

Authors
  1. Polly Roy PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meredith Stewart PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Polly Roy PhD .

Editor information

Editors and Affiliations

  1. Institute for Molecular Vaccines, Heidelberg, Germany

    Matthias Giese

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Wien

About this chapter

Cite this chapter

Roy, P., Stewart, M. (2013). Development of Safe and Efficacious Bluetongue Virus Vaccines. In: Giese, M. (eds) Molecular Vaccines. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1419-3_18

Download citation

Publish with us

Policies and ethics

Search

Navigation